DK1778677T3 - Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midler - Google Patents

Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midler

Info

Publication number
DK1778677T3
DK1778677T3 DK05781746.2T DK05781746T DK1778677T3 DK 1778677 T3 DK1778677 T3 DK 1778677T3 DK 05781746 T DK05781746 T DK 05781746T DK 1778677 T3 DK1778677 T3 DK 1778677T3
Authority
DK
Denmark
Prior art keywords
compounds useful
antidiuretic agents
heterocyclic condensed
condensed compounds
antidiuretic
Prior art date
Application number
DK05781746.2T
Other languages
English (en)
Inventor
Gary Robert William Pitt
Original Assignee
Vantia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vantia Ltd filed Critical Vantia Ltd
Application granted granted Critical
Publication of DK1778677T3 publication Critical patent/DK1778677T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05781746.2T 2004-08-20 2005-08-18 Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midler DK1778677T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60289004P 2004-08-20 2004-08-20
EP04104006A EP1627876A1 (en) 2004-08-20 2004-08-20 Heterocyclic condensed compounds useful as antidiuretic agents
PCT/EP2005/054081 WO2006018443A1 (en) 2004-08-20 2005-08-18 Heterocyclic condensed compounds useful as antidiuretic agents

Publications (1)

Publication Number Publication Date
DK1778677T3 true DK1778677T3 (da) 2010-04-19

Family

ID=34929464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05781746.2T DK1778677T3 (da) 2004-08-20 2005-08-18 Heterocykliske kondenserede forbindelser der er egnede som antidiuretiske midler

Country Status (21)

Country Link
US (1) US8063038B2 (da)
EP (2) EP1627876A1 (da)
JP (1) JP4705105B2 (da)
KR (1) KR100877336B1 (da)
CN (1) CN1968947A (da)
AT (1) ATE457026T1 (da)
AU (1) AU2005273875B2 (da)
CA (1) CA2567782A1 (da)
CY (1) CY1110619T1 (da)
DE (1) DE602005019241D1 (da)
DK (1) DK1778677T3 (da)
ES (1) ES2339786T3 (da)
HR (1) HRP20100250T1 (da)
IL (1) IL178839A0 (da)
MX (1) MX2007001861A (da)
NO (1) NO20071476L (da)
PL (1) PL1778677T3 (da)
PT (1) PT1778677E (da)
RU (1) RU2359969C2 (da)
SI (1) SI1778677T1 (da)
WO (1) WO2006018443A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1632494A1 (en) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
US9096546B2 (en) 2007-05-10 2015-08-04 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AU2009330686B2 (en) 2008-06-16 2014-07-03 The Ohio State University Research Foundation Compounds for the treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
CN102089289A (zh) * 2008-07-16 2011-06-08 弗·哈夫曼-拉罗切有限公司 用于治疗心血管疾病的新的杂环基化合物
WO2011005842A1 (en) 2009-07-09 2011-01-13 Gilead Sciences, Inc. Anti-rsv compounds
JP2011057661A (ja) * 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類
MX2012010115A (es) 2010-03-01 2013-02-26 Gtx Inc Compuestos para el tratamiento de cancer.
US9119878B2 (en) 2010-07-08 2015-09-01 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
EP2612662B1 (en) * 2012-01-04 2020-03-04 Wellesley Pharmaceuticals, LLC Delayed-release formulation for reducing the frequency of urination and method of use thereof
BR112014016550A8 (pt) * 2012-01-04 2017-07-04 Wellesley Pharmaceuticals Llc formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma
EP2612663A1 (en) * 2012-01-04 2013-07-10 Wellesley Pharmaceuticals, LLC Extended-release formulation for reducing the frequency of urination and method of use thereof
MX2014008283A (es) * 2012-01-04 2015-03-03 Wellesley Pharmaceutical Llc Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
RU2669565C2 (ru) * 2012-03-19 2018-10-12 УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения
US10596127B2 (en) 2013-03-14 2020-03-24 Wellesley Pharmaceuticals, Llc Composition for reducing the frequency of urination, method of making and use thereof
WO2014208296A1 (ja) * 2013-06-25 2014-12-31 イハラケミカル工業株式会社 ニトロベンゼン化合物を製造する方法
CN106810508B (zh) * 2017-01-05 2019-12-10 浙江农林大学暨阳学院 一种铁催化多组分反应合成苯并[1,4]-氧氮杂卓化合物的方法
WO2019003433A1 (ja) 2017-06-30 2019-01-03 大塚製薬株式会社 ベンゾアゼピン誘導体
CN114853728B (zh) * 2022-05-07 2023-11-07 四川制药制剂有限公司 一种富马酸伏诺拉生片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104853A (en) * 1992-02-27 1997-11-20 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
BR9811559A (pt) * 1997-07-30 2000-09-12 American Home Prod Agonistas tricìclicos de vasopressina
DE69826487T2 (de) * 1997-07-30 2005-12-01 Wyeth Trizyclische vasopressin-agonisten
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents

Also Published As

Publication number Publication date
RU2007101237A (ru) 2008-09-27
PL1778677T3 (pl) 2010-07-30
PT1778677E (pt) 2010-03-17
CN1968947A (zh) 2007-05-23
IL178839A0 (en) 2007-03-08
ATE457026T1 (de) 2010-02-15
SI1778677T1 (sl) 2010-09-30
KR100877336B1 (ko) 2009-01-07
CY1110619T1 (el) 2015-04-29
MX2007001861A (es) 2007-04-24
EP1778677A1 (en) 2007-05-02
HRP20100250T1 (hr) 2010-06-30
DE602005019241D1 (de) 2010-03-25
JP2008509972A (ja) 2008-04-03
NO20071476L (no) 2007-03-19
RU2359969C2 (ru) 2009-06-27
WO2006018443A1 (en) 2006-02-23
CA2567782A1 (en) 2006-02-23
AU2005273875B2 (en) 2009-08-27
EP1627876A1 (en) 2006-02-22
ES2339786T3 (es) 2010-05-25
HK1100290A1 (en) 2007-09-14
KR20070027761A (ko) 2007-03-09
US20080234250A1 (en) 2008-09-25
JP4705105B2 (ja) 2011-06-22
US8063038B2 (en) 2011-11-22
EP1778677B1 (en) 2010-02-03
AU2005273875A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
NO20071476L (no) Antidiuretiske midler.
MA29135B1 (fr) Potentialisateurs de recepteurs du glutamate
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
CY1112914T1 (el) Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
ATE429427T1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
CR20140316A (es) Derivados de indol como antagonistas receptores de s1p1 (divisional 10922)
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
CY1109015T1 (el) Διφαινυλ ενωσεις χρησιμες ως ανταγωνιστες μουσκαρινικου υποδοχεα
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
NO324217B1 (no) Kondenserte azepinderivater og deres anvendelse som antidiuretiske midler
CY1108880T1 (el) Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
ATE503755T1 (de) Cgrp-rezeptorantagonisten
EA200400454A1 (ru) Мускариновые агонисты
ATE411287T1 (de) Neue metallproteinaseinhibitoren
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
BRPI0516602A (pt) composto, e, composição farmacêutica
EA200801139A1 (ru) Композиция для аэрозольной ингаляции
EA200701881A1 (ru) 1,3-тиазол-5-карбоксамиды, используемые в качестве противораковых химиотерапевтических агентов
TH76960A (th) สารผสมการย้อมสีเส้นผม ซึ่งประกอบรวมด้วย สารประกอบ 2-(อะมิโน หรือซับสทิทิวเทดอะมิโน)-3-5- ซับสทิทิวเทด ฟีนอล และการใช้ของสารผสมเหล่านี้
SE0303419D0 (sv) New use 11